Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients
1990 ◽
Vol 228
(5)
◽
pp. 457-464
◽
1985 ◽
Vol 61
(3)
◽
pp. S147-S148
1986 ◽
Vol 46
(5)
◽
pp. 471-475
◽